Researchers who support them are approaching United State From finding a vaccine that could prevent people from being infected with HIV – HIV – The cause of AIDS , Giving hope to millions of people around the world.
People in their twenties who are living with HIV can expect to live an additional 53 years on average and may not AIDS Never, thanks to the many types of treatments used for antiretroviral therapy.
“The success of different treatment methods [in containing the disease] is very astounding,” says Dr. Anthony Fussie, director of the National Institute of Allergy and Infectious Diseases. “But while treatments prolong the lives of people infected with HIV HIV , It is regrettable that some 1.8 million people have contracted the virus in 2016, according to UN estimates.
Two experiments are in progress
Fusi spoke of two practical experiences, partly funded by the National Institutes of Health, which are currently underway in the South Africa , May lead to the discovery of a vaccine that could eventually prevent new infections HIV .
The first study, called ” Imbukudu “, Aimed at registering 2,600 women in the area Africa To help assess the safety and effectiveness of experimental vaccines. The word ” Imbukudu “Zulu means” rock “, referring to the power and importance of women in society.
The ” Imbukudu “, Led by a company Johnson & Johnson (Johnson & Johnson), based in New Jersey, eventually expanded to Malawi, Mozambique, Zambia and Zimbabwe. The researchers expect the results to appear in 2021.
Said Kathy Mengadi of the Center for AIDS Research in the South Africa In a statement, both experiments “represent the best current scientific effort to develop a vaccine to prevent HIV infection” HIV ). We are grateful to people from the southern regions of the continent Africa Who volunteer for these experiments, and for the communities in which they are being tested to help develop what can be a real change for the HIV / HIV ), The Council for Medical Research in South Africa On the implementation of the study in South Africa .
Historically, it was the search for a vaccine against a virus HIV Is a challenge, partly because of the unique characteristics of the virus, including its ability to rapidly shift, and its genetic diversity worldwide in the form of multiple strains and subtypes prevalent in different parts of the world, according to Johnson & Johnson.
Why treatment is still important
“Despite all the scientific advances that have been made [in treating and preventing a virus HIV ] We have serious gaps in implementation and implementation. “Fosse noted that 30 percent of new infections do not know they are infected, and 60 percent do not receive proper treatment.
“We can end the epidemic fundamentally by improving implementation and implementation,” he said. “But we can not stop working and moving on.”
This article by independent author Wesley Thompson
To read the article in our website, use the link: